Market Place
Sourcing Support
Health Canada Issues Recall of Sandoz`s Fesoterodine Fumarate
16 May 2024 //
HEALTH CANADA
Hetero`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
09 Jan 2024 //
FDA
Lupin`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
05 Jan 2023 //
FDA
Amneal Pharm`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
Actavis Lab`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
ANI Pharm`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
Accord healthcare`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
Amerigen`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
12 Oct 2022 //
FDA
Dr. Reddy`s Laboratories Launches Fesoterodine Fumarate ER Tablets in U.S.
09 Jul 2022 //
NASDAQ
Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate ER tablets
02 Feb 2022 //
ECONOMIC TIMES
Alembic Pharms` Generic Fesoterodine Fumarate Receives Approval in the U.S.
31 Jan 2022 //
FDA
Amneal Pharm`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
21 Jan 2022 //
FDA
Actavis Lab`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
11 Jan 2022 //
FDA
Mylan Pharms`s fesoterodine fumarate Receives Tentative Approval in US
14 Aug 2020 //
FDA
Four pharmas named for breaching ABPI Code of Practice
20 Jul 2018 //
PHARMA TIMES
Zydus Pharm’s Generic Fesoterodine Fumarate Receives Approval in US
07 Oct 2017 //
FDA
USFDA approves aurobindo’s ANDA for pfizer’s toviaz
03 May 2016 //
TWO FOUR INSIGHT
Amerigen Gets Tentative FDA Approval for Generic Toviaz
11 May 2015 //
FDA NEWS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.